Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Mar 21;12(11):1743-6.
doi: 10.3748/wjg.v12.i11.1743.

Expression of Ets-1 proto-oncoprotein in gastrointestinal stromal tumors, leiomyomas and schwannomas

Toshiyuki Nakayama  1 , Ayumi Yoshizaki, Shinji Naito, Chun-Yang Wen, Gabit Alipov, Yuichi Yakata, Ichiro Sekine
Affiliations

Expression of Ets-1 proto-oncoprotein in gastrointestinal stromal tumors, leiomyomas and schwannomas

Toshiyuki Nakayama et al. World J Gastroenterol. .

Abstract

Aim: Gastrointestinal stromal tumors (GISTs) are rare. GISTs differ from other mesenchymal tumors of the gastrointestinal tract (e.g. leiomyomas and schwannomas). The purpose of this study was to investigate the role of Ets-1 in the growth and differentiation of GISTs.

Methods: Twenty-eight GISTs, nine leiomyomas and six schwannomas were examined by immunohistochemical staining method for Ets-1 in this study. Specimens were selected from surgical pathology archival tissues at Nagasaki University Hospital.

Results: Ets-1 protein was expressed in the cytoplasm of cells in all of these tumors. Immunohistochemical staining revealed that 27 GISTs (96.4%), six leiomyomas (66.7%), and five schwannomas (83.3%) were positive for Ets-1. Ets-1 expression was statistically different between GISTs and leiomyomas (P<0.005). However, there was no correlation between Ets-1 expression and clinical risk categories.

Conclusion: Ets-1 plays an important role in the growth and differentiation of GISTs, leiomyomas and schwannomas.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Ets-1 expression in GISTs (A-C), Leiomyomas (D) and Schwannomas (E). (magnification; A, B:x20, C: x 200, D, E: x100).
See this image and copyright information in PMC

References

    1. Miettinen M, Lasota J. Gastrointestinal stromal tumors-- definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch. 2001;438:1–12. doi: 10.1007/s004280000338. - DOI - PubMed
    1. Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J. Esophageal stromal tumors: a clinicopathologic, immunohistochemical，and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol. 2000;24:211–222. doi: 10.1097/00000478-200002000-00007. - DOI - PubMed
    1. Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J. Gastrointestinal stromal tumors and leiomyosarcomas in the colon: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases. Am J Surg Pathol. 2000;24:1339–1352. doi: 10.1097/00000478-200010000-00003. - DOI - PubMed
    1. Ranchod M, Kempson RL. Smooth muscle tumors of the gastrointestinal tract and retroperitoneum: a pathologic analysis of 100 cases. Cancer. 1977;39:255–262. doi: 10.1002/1097-0142(197701)39:1<255::AID-CNCR2820390139>3.0.CO;2-H. - DOI - PubMed
    1. Shiu MH, Farr GH, Papachristou DN, Hajdu SI. Myosarcomas of the stomach: natural history, prognostic factors and management. Cancer. 1982;49:177–187. doi: 10.1002/1097-0142(19820101)49:1<177::AID-CNCR2820490136>3.0.CO;2-K. - DOI - PubMed

MeSH terms